Background {#Sec1}
==========

Aging is associated with a decrease of muscle strength and power \[[@CR1]--[@CR3]\]. The term dynapenia, coined by Manini and Clark \[[@CR3]--[@CR5]\], best describes the condition of decreased muscle strength and power instead of the term sarcopenia. The latter only refers to an age-related loss in skeletal muscle mass. Muscle weakness is related to falls, lower walking speed, functional limitation, a decrease in mobility, and disability \[[@CR6]--[@CR8]\]. In this context, the elderly are viewed as a group of people in need \[[@CR9]\]. When physical functioning is concerned there often is a mismatch between chronological age and biological age. Chronological age is not necesarilly related to physical capabilities. For this reason, a classification of elderly based on physical abilities; e.g. physical and mental functions is more appropriate.

Zeyfang and Braun \[[@CR10]\] classified older adults as "*being an independent person*" (Go-Go); "*being a needy person with a slight handicap*" (Slow-Go); and "*being a person in need of care with severe functional limitation*" (No-Go). The need for care may be defined as depending permanently on assistance (No-Go) or depending on support in everyday activities such as dressing, body care, eating, using the toilet, mobility, and planning the day (Slow-Go) \[[@CR11]\].

The ability of elderly individuals to perform basic activities of daily life is crucial for their ability to exist independently \[[@CR12]\]. To improve and/or enable performance of basic activities of daily life, exercise programs are indicated. Sensorimotor training and resistance exercises are effective methods to increase muscle mass and strength in the elderly \[[@CR13]\]. Whole-body vibration (WBV) can be used as a sensorimotor training regimen. The impact of WBV on the body is low according to indicators such as blood pressure, heart rate, lactate, and O~2~ uptake \[[@CR14]--[@CR16]\]. Systematic reviews concluded that, compared to more demanding interventions, WBV might be a safer and less fatiguing type of exercise \[[@CR17]\] with a beneficial effect on movement skills \[[@CR18]\].

Three types of WBV are used based on the amount of vibrating plates \[[@CR18], [@CR19]\]. Sinusoidal vertical whole-body vibration (SV-WBV) and sinusoidal side-alternating whole-body vibration (SS-WBV) use a single vibrating platform, whereas stochastic resonance whole-body vibration (SR-WBV) expects the trainees to stand on two platforms. During sinusoidal WBV the participants stand on a platform that vibrates vertically (SV-WBV) or to the side alternating (SS-WBV) with a high frequency between 20 and 50 Hz and an amplitude between 2 and 14 mm \[[@CR20]\]. SR-WBV vibrates with frequencies between 1 and 12 Hz and an amplitude between 3 and 6 mm while the feet of the participants are placed on two independent powered and stochastic vibrating platforms \[[@CR20]\].

In recent years, WBV has been introduced as a training method to improve muscle power and strength \[[@CR21]--[@CR23]\]. Several systematic reviews \[[@CR24], [@CR25]\] report on strength-related outcomes. However, no review has considered muscle strength related outcomes in a comparison of WBV against non-exercising control or conventional exercise groups and no review evaluated the effects separately for groups differing in initial levels of physical functioning, e.g. the three groups "Go-Go, Slow-Go and No-Go". This is of relevance, however, since training principles would let us expect that those with the lowest level of fitness have greatest room for improvement. In other words, improvement in the outcome of interest will be greatest in those with lower initial values \[[@CR26]\]. Furthermore, no review includes stochastic resonance WBV.

For clinicians, a systematic overview about the relevance and indication for application of SV-WBV, SS-WBV or SR-WBV and how it might be applied for Go-Go, Slow-Go and No-Go elderly individuals is lacking. Therefore, the aims of this systematic review are to provide 1) an overview of the current studies on WBV, 2) to determine the effects of WBV on strength or power in Go-Go, Slow-Go and No-Go elderly individuals and 3) give recommendations on available evidence for practical use. We hypothesized that WBV differently effects on measures of strength and power in Go-Go, Slow-Go and No-Go.

Methods {#Sec2}
=======

Data sources and searches {#Sec3}
-------------------------

Inclusion criteria and analysis methods were developed and documented in a protocol prior to the current review. Included were elderly over 65 years of age; excluded were Geriatric diseases (Parkinson disease, Stroke, Multiple sclerosis), studies applying electrical current vibration or vibration with shoe insoles. More detailed information on the protocol including a link to the search strategy can be found on <http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42013006489> (PROSPERO registration number 2013:CRD42013006489). This systematic review and meta-analysis followed the PRISMA guidelines \[[@CR27]\].

A first literature search of electronic databases was repeatedly carried out from January 2013 to February 2014 in the PubMed, CENTRAL (Cochrane Central Register of Controlled Trials), Physiotherapy Evidence Database (PEDro) and CINAHL electronic databases. The International Clinical Trials Registry Platform from the World Health Organization (WHO) was also searched. In February 2015 the search was repeated shortly before submission of the manuscript to ensure inclusion of most recent relevant material in the review. Additionally, a manual search of the reference lists of retrieved publications was conducted. English and German language restrictions were imposed upon the search.

Systematic search {#Sec4}
-----------------

The following keywords and combinations according to the PICO-model \[[@CR28]\] were used in the search strategy:Population: elderly, aged, dwelling home, nursing home, human research.Intervention: Whole Body Vibration, WBV, noise, random vibration, RCT.Comparator: WBV against control intervention (non-exercise or exercise on a level too low to effect on muscle \[[@CR29]\]), WBV against conventional strength training intervention.Outcome: strength, maximal voluntary contraction, power, rate of force development, performance, falls. Our search terms are detailed in Additional file [1](#MOESM1){ref-type="media"}.

Based on the four PICO components, a final question was stated as: For an older adult with diminishing physical capacity, will whole body vibration (WBV) exercise as compared to non- or conventionally exercising older adults improve muscle strength and/or power?

The following aspects were operationalized: 1) assessment of the quality and internal validity of the studies reviewed; 2) description of the assessments used to document the effect of WBV on isometric maximal voluntary contraction (IMVC), dynamic strength (DS), power, rate of force development (RFD) and functional strength (FS); 3) composition of the WBV training parameters; and 4) conclusion about clinical relevance in general.

Study selection {#Sec5}
---------------

Five independent reviewers (CJ, CW, NJS, SR, RH) screened the titles and abstracts for eligibility. They screened for randomized controlled trials (RCTs) measuring maximal voluntary contraction, power and rate of force development in studies using WBV intervention in elderly individuals (mean age at least 65 years). Full text articles in English or German were eligible for inclusion. Healthy elderly participants and all clinical outcome measures of IMVC, DS, power, RFD, and FS were included in this review. Studies describing vibrations applied by electrical current or vibrating insoles, and patient series were excluded.

In the event of missing data, additional information was requested from the corresponding authors in order to include these data in our meta-analysis.

Data extraction {#Sec6}
---------------

In addition, general characteristics of the studies were extracted. Five authors (CJ, CW, NJS, SR, RH) independently abstracted the following information from each of the studies included in this review: 1) design and sample; 2) inclusion criteria; 3) training parameters (i. e. duration, frequency, intensity of WBV); 4) type of vibration plate; 5) change in strength, power, RFD; 6) conclusions of the studies and statistical significance.

Methodological quality assessment of studies {#Sec7}
--------------------------------------------

The methodological quality of the included articles was rated with the "Cochrane Collaboration tool for assessing risk of bias" (RoB) \[[@CR30]\] to assess the risk of over- or under-estimating the effects of an intervention \[[@CR31]\].

Nine items, with each having three rating categories, were scored and divided into six domains of bias (Fig. [2](#Fig2){ref-type="fig"}): (1) low ROB, (2) unclear ROB and (3) high ROB. Rating (1) is unlikely to alter the results significantly, (2) raises some doubt about the results and (3) seriously weakens confidence in the results. With insufficient information on an item, the score given was "high risk". The arbitration of a third reviewer was used in the event of any disagreement between the reviewers (YB, RH) for both ratings.

Data synthesis and analysis {#Sec8}
---------------------------

Most outcomes of interest were presented as continuous data (mean values and SD or mean changes). For the meta-analysis of the present study the standardized mean difference (SMD) and 95 % confidence interval (CIs) of the post-intervention values or changes in scores were used for all comparisons. SMDs were pooled with a random effects model. The magnitude of the effect sizes for the between groups comparisons, calculated by SMDs are interpreted as follows: an effect size (d) around 0.2 indicates a small effect size, around 0.5 a medium effect size, and around 0.8 a large effect size \[[@CR32]\]. If only one study was identified or data were not presented in a format that allowed inclusion in the dataset, results of individual studies are presented. If studies reported more than one IMVC, DS, power or RFD, and FS; then we only extracted the first outcome data on a hierarchy of outcomes:IMVC: 1. isometric knee extension, 2. isometric hip extension, 3. isometric leg press; DS: 1. dynamic leg press, 2. dynamic knee extension (lowest speed), 3. dynamic hip extension; Power: 1. leg press, 2. knee extension; RFD: 1. counter movement jump, 2. squat jump, 3. leg press,; FS: 1. chair rise time, 2. chair rise repetition, 3. chair rise power, 4. stair climb, 5. wall squat. Subgroup analyses were undertaken to assess the effects of WBV on IMVC, DS, power, RFD and FS in Go-Go, Slow-Go and No-Go.

Heterogeneity was assessed by forest plots and the I^2^ statistics. Values \>25 % indicate small, \>50 % middle and \>75 % considerable heterogeneity \[[@CR33]\]. All other information was summarized and analysed qualitatively. Stata (version 13) was used for all meta-analyses.

Results {#Sec9}
=======

Study selection {#Sec10}
---------------

The literature search yielded 1383 studies (PubMed *n* = 394, Central *n* = 163, Cinahl = 446, Embase = 174, Pedro *n* = 144, ScienceDirect *n* = 29, WHO International Clinical Trials Registry Platform *n* = 33). After identification of 367 duplicates, 1016 titles and abstracts were screened. Seventy-nine studies remained for further full-text analysis. Subsequently, 41 studies were excluded because they did not address strength, power or rate of force development or included participants with diseases. Finally, 38 full text papers \[[@CR20], [@CR23], [@CR34]--[@CR64]\] were included for this review and 37 were used for the meta-analysis (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Flow diagram

Study characteristics {#Sec11}
---------------------

The major characteristics of the included studies are summarized in Table [1](#Tab1){ref-type="table"}. Three papers investigated the effects on force by vertical and side-alternating sinusoidal WBV \[[@CR35], [@CR46], [@CR66]\]. Five studies included more than 100 participants. Leung et al. \[[@CR66]\] (*n* = 596), Boegarts et al. \[[@CR38]\] (*n* = 180), Kemmler et al. \[[@CR44]\] (*n* = 151) von Stengel \[[@CR59]\] (*n* = 151) and Sitjà-Rabert et al. \[[@CR64]\] (*n* = 117). The other included studies had a small sample size of less than 100 participants. The used strength outcomes varied across all included studies.Table 1Study characteristics of the included studiesStudyParticipants (N, sex distribution); mean age (± SD)Protocol exerciseOutcome measuresWithin GEBetween GE(yes/no)(yes/no)Vertical sinusoidal vibrationAmaral et al. \[[@CR78]\]WBV: 9 ♀; 76.6 (±11.8)WBV: isometric squatFS: CR over 30 sNoNoCon: 9 ♀; 78.6 (±10.4)Con: daily activities routinesÁlvarez- Barbosa et al. \[[@CR62]\]WBV: 15, 12 ♀; 84.0 (±3.0)WBV: dynamic exercise lunge, squat, calf raises, left and right pivot in a front and lateral position, step up and down.FS: CR over 30 sYesYesCon: 15, 11 ♀; 86.0 (±7.5)Con: no change lifestyleBautmans et al. \[[@CR34]\]WBV: 10, 8 ♀; 76.6 (±11.8)WBV: static position exercises (lunge squats, squats, deep squats, wide stance squats, calves, calves deep) druing WBVDS: (N)YesNOPower: (W), work (J)Sham: 11, 6 ♀; 78.6 (±10.4)RFD: (N/s) at 40 and 60 cm/sBeck et al. \[[@CR35]\]WBV: 15 ♀; 68.5 (±8.6)Pos: full extensionFS: wall squat with dominant leg and non dominant leg & CR over five repetitions (s)YesNoCon: 15 ♀; 74.2 (±8.1)Con: no vibrationBogaerts et al. \[[@CR37]\]WBV: 25 ♂; 66.9 (±0.7)WBV: squat, deep squat, wide stance squat, toesstand, toes-stand deep, one-legged squat, and lunge.IMVC: knee extension (Nm)YesYesEx: 25 ♂; 67.4 (±0.9)Con: 32 ♂; 68.6 (±1.0)Ex: cardio exercise, strength and balance training, flexibility exerciseRFD: CMJ (cm) on a contact mat.Con: no change lifestyleBogaerts et al. \[[@CR38]\]WBV: 70; 66.8WBV: exercises for upper and lower bodyIMVC: knee extension (Nm)YesNoEx: 49: 66.8Ex: cardio exercise, strength and balance training, flexibility exerciseCon: 61; 67.8 (ratio ♂:♀ = 1.5:1 for the total sample)Con: no change life styleBoegarts \[[@CR36]\]WBV 1: 26 ♀; 80.3 (±5.3)WBV: squat, deep squat, wide stance squat, toes stand and one legged squatPhysiological Profile Assessment \[[@CR76]\]:YesNoWBV 2: 28 ♀; 79.8 (±5.3)Con 1 & 2: no change life styleIMVC: knee extension (kg)Con 1: 29 ♀; 78.7 (±5.6)Con 2: 28 ♀; 79.6 (±5.2)Corrie et al. \[[@CR65]\]WBV: 21, 13 ♀; 81.9 (±5.7)WBV: standing position, with bent knees and Otago Exercise programmPower: (W/kg body weight) leg pressYes (power & CR)Yes (power)Sham: 20, 16 ♀; 79.1 (±7.8)Sham: Otago Exercise program which consisted of 6 weekly visitsRFD: CMJ (N/kg body weightFS: CR over five repetitionsGomez-Cabello \[[@CR42]\]WBV: 24WBV: squat positionSenior Fitness Test battery and Eurofit Testing Battery \[[@CR77]\]:YesNoCon: 25 (20 ♂, 29 ♀)Con: no change life styleFS: CR over 30 s (repetition)Kemmler et al. \[[@CR44]\]WBV: 50 ♀; 68.8 (±3.6)WBV: static and dynamic exercise (toe stand, squat)IMVC: leg press (N)YesYesEx: 50 ♀; 68.6 (±3.0)Ex: static and dynamic exercise (toe stand, squat) without vibrationPower: leg press (W/kg)Con: 51 ♀; 68.1 (±2.7)Con: exercise and relaxation program once a week (30× 60 min)RFD: leg press (N/ms) & Squat jump (jump height, cm)Kennis et al. \[[@CR45]\]WBV: 23 ♂WBV: static and dynamic squat, deep squat, wide stance squat, 1-legged squat, lunge, toes-stand, toes-stand deep, moving heels.IMVC: at 120° knee extension (Nm)YesNoEx: 20 ♂Con: 29 ♂Ex: 60--90 min aerobic, resistance, balance, and flexibility exercisesDS: concentric dynamic knee extension (Nm) at a movement velocity at 120°/s.Con: no change life styleRFD: counter movement jump (high, cm)Klarner et al. \[[@CR46]\]WBV: 36 ♀; 68.1 (±4.0)WBV: dynamic exercisesIMVC: with leg press (N)YesYesCon: 36 ♀; 67.6 (±4.13)Con: 1/w low gymnastic exercise & relaxation exerciseRFD: with Counter movement jump (CMJ, jump height, cm)Lachance \[[@CR47]\]WBV: 26; 70.4 (±7.7)WBV: static squats (60°), lunges (60°) and heel raises.FS: CR over 30 sYesNoEx: 29; 75.9 (±7.2)Ex: static squats (60°), lunges (60°) heel raises, bicep curls, tricep extensions,(33 ♂, 22 ♀)Exercises were progressive in nature by safely increasing the number of repetitions completed and/or weight of the dumbbells.Leung et al. \[[@CR66]\]WBV: 280 ♀; 74.2 (±7.0)WBV: standing upright without knee bandingIMVC: knee extensor (kg)YesYesCon: 316 ♀; 71.0 (±7.0)Non: no change life styleMachado et al. \[[@CR48]\]WBV: 13 ♀; 79.3 (±7.3)WBV: static and dynamic exercise (half-squat (120--130°), deep squat (knee angle 90°), a wide-stance squat and calves.IMVC: leg extensor (N)YesYesCon: 13 ♀; 76.2 (±8.4)Con: no change life stylePower: output at three relatives loads: 20, 40, 60 % of the IMVC.Mikhael et al. \[[@CR49]\]WBV1: 6, 4 ♀; 63.3 (±7.6)WBV: WBV1 with flexed knees at 20° and WBV 2 with extended knees.DS: one repetition maximum (1RM) leg press (N), relative strength (kg/kg), leg press strength (kg)YesYesWBV2: 5, 3 ♀; 69.0 (±7.6)Sham: flexed knees at 20° without vibrationPower: (W) and velocity (cm/s) were measured at 20, 30, 40, 50, 60, 70, 80, 90, and 100 % of current 1RM.Sham: 8, 4 ♀; 62.3 (±8.8)FS : CR over 30 sRoelants et al. \[[@CR53]\]WBV: 30 ♀; 64.6 (±0.7)WBV: high squat (120° and 130°, deep squat (90°), wide-stance squat and lunge.IMVC: (0°/s) torque (Nm) of knee extensorYesNoEx: 30 ♀; 63.9 (±0.8)Ex: resistance exerciseDS: dynamic extension-flexion movements (torque: N/m) between 90 and 160° at a velocity of 50, 100 and 150°/s.Con: 29 ♀; 64.2 (±0.6)Con: no change life styleRFD: jump height (mm) on a contact matSitjà-Rabert et al. \[[@CR64]\]WBV: 59; 64.6 (±0.7)WBV: static/dynamic exercises.FS: CR over five repetitionsYesNoEx: 58; 63.9 (±0.8)Ex: static and dynamic exercise(Total sample 67 % ♀)Verschueren et al. \[[@CR58]\]WBV: 25 ♀; 64.6 (±3.3)WBV: static and dynamic knee-extensor exercises like squat, deep squat, wide-stance squat, one-legged squat and lunge.IMVC: knee-extensionYesYesEx: 22 ♀; 63.9 (±3.8)Ex: warm-up, resistance training knee-extensor on a leg extension and a leg press machine. Designed to the guideline of the American College of Sports MedicineDS: isokinetic extension-flexion movements for maximal DS (peak torque N/m) at a velocity of 100°/s between of 90 and 160° joint angle.Con: 24 ♀; 64.2 (±3.1)Con: no change life styleVerschueren et al. \[[@CR57]\]WBV: 28 ♀; 79.8 (±5.3)WBV: static and dynamic knee-extensor exercises like squat, deep squat, wide-stance squat, one-legged squat and toe-stance.IMVC: Knee-extension (Nm)YesNoCon: 28 ♀; 79.6 (±5.2)Con: no change in life styleDS: Knee-extension (Nm).Sidealternating sinusoidal vibrationBeck et al. \[[@CR35]\]WBV: 17 ♀; 68.9 (±70)Pos: static with slightly bended kneesFS: wall squat dominant leg (DL) and non dominant leg (NDL) & CR over five repetitions (s)Yes =NoCon: 15 ♀; 74.2 (±8.1)Con: no vibrationCalder et al. \[[@CR39]\]N: 41, 30 ♀; 80.1WBV: stand with slightly bended knees (35° flexion) & PhysiotherapyFS: CRYesNoCon: PhysiotherapyCorrie et al. \[[@CR65]\]WBV: 21, 16 ♀; 81.9 (±5.7)WBV: standing position, with bent knees and Otago ExercisePower: (W/kg body weight) leg pressNoNoSham: 20, 8 ♀; 79.1 (±7.8)Sham: Otago Exercise program which consisted of 6 weekly visitsRFD: CMJ (N/kg body weightFS: CR over five repetitionsFurness and Maschette \[[@CR40]\]WBV1: 18 (1/week)WBV: static with 70 knee flexionFS: CRYes (for WBV2 and WBV3)NoWBV2: 18 (2/week)Con: no vibrationWBV3: 19 (3/week)Age: 72 (±8)Con: 18 (0/wk)(Total sample 38 ♂, 35 ♀)Furness et al. \[[@CR41]\]WBV: 19WBV: static with 70° KneeflexionFS: CRYesNoCon: 18Con: no exercise(Total sample 16 ♂, 21 ♀)Iwamoto et al. \[[@CR43]\]WBV: 26 ♀; 72.4 (±8.1)WBV: stands with bended knee and hipsFS: CR over 5 timesYesNoCon: 26 ♀; 76.0 (±7.4)Con. No exerciseKlarner et al. \[[@CR40]\]WBV: 36 ♀; 67.9 (±3.78)WBV: dynamic exercisesIMVC: Hip & Knee extension (N)YesYesCon: 36 ♀; 67.6 (±4.13)Con: 1/w low gymnastic exercise & relaxation exerciseRFD: CMJ (jump height, cm)Ochi et al. \[[@CR67]\]WBV: 10 ♀; 80.9 (±2.8)WBV: dynamic exercisesIMVC: Quadiceps muscle dominant legYesNoEx: 10 ♀; 80.2 (±3.3)Con: dynamic exercise: half squat, heel rise, toe up.Raimundo et al. \[[@CR50]\]WBV: 14 ♀; 66 (±6)WBV: static with knee angle 120°DS: dynamic maximal unilateral strength at 60 and 300 °/s for concentric and eccentric at 60 °/s (Peak torque (Nm/kg).YesYesEx: 13 ♀; 66 (±4)Ex: walk-based-programmePower (W).Walking over 60 m with two sets with 70--75 % of their maximal heart rate.RFD: mixed counter movement jump onErgo Jump Platform (Bosco System, Italy)FS: CR over three repetitions.Rees et al. \[[@CR51]\]WBV: 15; 74.3 (±5.0)WBV: static squats over 4 weeks, than dynamic squats and calf raises over 4 weeks.DS: angular velocity 60°/s for knee and hip and the angle joint was tested at 30 °/s.YesYesEx: 13; 73.1 (±4.1)Ex: static squats over 4 weeks, than dynamic squats and calf raises over 4 weeks, without vibration.FS: CR over five repetitionCon: 15; 73.1 (±4.6)(Total sample 23 ♂, 20 ♀)Rees et al. \[[@CR52]\]WBV: 15; 74.3 (±5.0)Con: only walking WBV: static and dynamic exercise (squats, calf raises)DS: as torque (Nm/kg)YesNoEx: 13; 73.1 (±4.1)Ex: same exercise without vibrationmaximum isokinetic power (W/kg) angular velocity for the hip and knee was 60°/s, with the ankle joint tested at 30°/s.(No sex distribution information)Russo et al. \[[@CR55]\]WBV: 17 ♀WBV: static, knees slightly flexedDS: strength (N), acceleration of the centre of gravity (COG) was calculated as the ratio of force (N) and body mass (kg).YesNoAge: 60.7 (±6.1)Con: no change in life styleRFD: starting from a standstill, jumped as high as possible and landed (W).Con: 16 ♀Age: 61.4 (±7.3)Sievänen et al. \[[@CR61]\]WBV: 8, 7 ♀WBV: dynamic exercise such as slight squatting, toe raises, lateral weigth transfer.FS: SPPBYesNOAge: 84.4 (±6.3)Ex: light squatting, toe raises or weight transfer forward and lateral weight transfer on WBV.Sham: 7, 5 ♀Age: 83.6 (±8.9)Stolzenberg et al. \[[@CR56]\]WBV: 30 ♀; 67.5 (±3.8)WBV: static standing with slightly bent knees and hips, continuous squatting from erect standing to 90° knee flexion or static stance in 90° knee flexionPower: CMJ (W/kg)YesNoCon: 30 ♀; 65.5 (±4.3)Con: balance exercise like Romberg, tandem and single-leg stance.RFD: CMJ jump height (cm)FS: 1-leg hopping and CR over five repetitionsvon Stengel et al. \[[@CR59]\]WBV: 50♀; 68.8 (±3.6)WBV: heel rise, one-legged deep squat, and leg abductionMVC: leg press (N)YesYesEx: 50 ♀; 68.6 (±3.0)Ex: heel rise, one-legged deep squat, and leg abduction without vibrationRFD: CMJ (W/Kg)Con: 51 ♀; 68.1 (±2.7)Con: exercise and relaxation program once a week in blocks of 10 weeks with breaksZhang et al. \[[@CR60]\]WBV: 19, 2 ♀; 85.8 (±3.6)WBV: different to their function. Who could stand: partial squat position with slight hip, knee and ankle joint flexion. Who could not stand independently, same position, but were allowed to hold the support bar with their hands.IMVC: M. quadricepsYesYesCon: 18, 3 ♀; 84.7 (±3.7)Ex: usual care, physical therapy (ultrasound therapy, electrical stimulation, etc.) and routine exercises, such as pedalling training with regular dosage and time of treatments.FS: CR over 30 sStochastic resonance vibrationKessler et al. \[[@CR23]\]WBV: 10, 8 ♀; 77 (±7.7)static (e.g. normal stance, semi-tandem, one leg stance) and dynamic standing (e.g. squat)IMVC: knee-extension (N)YesYesSham:10, 8 ♀; 81 (±5.7)RFD: knee-extension (N/s)FS: SPPBRogan et al. \[[@CR54]\]WBV: 10; 77 (±7.7)static standing with slightly bent knees and hipsFS: CR (1 time)YesNoSham:10; 81 (±5.7)(No sex distribution information)Rogan et al. \[[@CR20]\]WBV: 5; 77 (±7.7)static standing with slightly bent knees and hipsIMVC: knee-extension (N)YesNoSham: 4; 81 (±5.7)RFD: knee-extensor (N/s)(Total sample 4 ♂, 5 ♀)FS: SPPB*Abbreviation*: *Con* control group, *EX* exercise group, *Sham* sham group; *SD* standard deviation, *GE* group effests, *mo* month, *wk* week, *WBV* whole-body vibration, *Pos* position, *s* seconds, *IMVC* isometric maximal voluntary contraction, *DS* dynamic maximal strength, *RFD* rate of force development, *FS* functional strength, *CR* chair rising, *CMJ* counter movement jump, *SPPB* Short Physical Performance Battery Test, *cm* centimetre, *mm* millimetre, *N* newton; *N/s* Newton/seconds, *Nm* Newton-metre, *Nm/kg* Newton-meter/kilogram, *N/ms* Newton/milliseconds, *kg* kilogram, *J* Joule, *W* watt, *W/kg* watt/kilogram

Table [2](#Tab2){ref-type="table"} shows the training parameters. All authors prescribed two to three WBV sessions per week. Intervention duration of six trials were lasting more than 1 year \[[@CR37], [@CR38], [@CR44], [@CR46], [@CR59], [@CR67]\]. The duration of ten trials \[[@CR35], [@CR36], [@CR42], [@CR43], [@CR50], [@CR55]--[@CR58], [@CR53]\] was between 6 months and 1 year. The other trials lasted less than 6 months while one study examined strength effects immediately after a single WBV intervention \[[@CR20]\]. The training parameters such as amplitude, frequency and sets of WBV varied across all studies investigating sinusoidal WBV. In contrast, studies with SR-WBV were more homogenous.Table 2Overview of trainings parameter within each studyStudyDuration/(Session/per week)AmplitudeFrequencySets, Duration, Rest between setVertically sinusoidal vibrationAmaral et al. \[[@CR78]\]12 weeks/(3/week)2--4 mm30--40Hz3 sets × 30--45 s.Álvarez- Barbosa et al. \[[@CR62]\]8 weeks/(3/week)4 mmF: 30--35Hz6--12 sets, 12--17 min total time, 45 s rest between setBautmans et al. \[[@CR34]\]6 weeks/(3/week)2--5 mm30--40 Hz4 sets × 30--60 s, 30--60 s rest between setBeck et al. \[[@CR35]\]32 weeks/(2/week)0.3 g30 Hz15 min (1 session), no restBogaerts et al. \[[@CR37]\]47 weeks/(3/week)2.5--5 mm30--40 Hz4 sets sets × 30 s -- 15 × 30 s, 15--30 s rest between setBogaerts et al. \[[@CR38]\]48 weeks mo/(3/week)NANANABoegarts \[[@CR36]\]24 weeks/(3/week)1.6--2.2 g30--40 Hz3 sets × 15--60 s, 60--5 s rest between setCorrie et al. \[[@CR65]\]12 weeks/(3/week)1.3 mm30 Hz3 to 6 sets × 20 to 60 s, 60 s rest between setGomez-Cabello \[[@CR42]\]44 weeks mo/(3/week)2 mm40 Hz10 sets × 45 s, 60 s rest between setKemmler et al. \[[@CR44]\]88 weeks/(2/week)NA25--35 HzNAKennis et al. \[[@CR45]\]2.5--5 mm30--40 Hz4 sets × 30 s till 15 sets × 30 s, 15--30 s rest between setKlarner et al. \[[@CR46]\]48 weeks mo/(3/week)35 Hz7 sets × 90 s, 40 s rest between setLachance \[[@CR47]\]8 weeks/(2/week)2 mm35 HzNALeung et al. \[[@CR66]\]72 weeks mo/(5/week)2 mm35 Hz20 min, rest (NA)Machado et al. \[[@CR48]\]10 week/(3--5/week)2--4 mm20--40 Hz3--8 sets × 30--60 s, rest (NA)Mikhael et al. \[[@CR49]\]12 weeks/(3/week)1 mm12 Hz10 sets × 60 s, 60 s rest between setRoelants et al. \[[@CR53]\]24 weeks/(3/week)2.5--5 mm35--40 Hz1--3 sets × 30--60 s of one exercise, 60 to 5 s rest between setSitjà-Rabert et al. \[[@CR64]\]6 weeks/(3/week)2--4 mm30--35 Hz3 sets × 30--60 s of one exercise, 60 to 5 s rest between setVerschueren et al. \[[@CR58]\]24 weeks/(3/week)1.7--2.5 mm35--40 HzNAVerschueren et al. \[[@CR57]\]18 weeks/(3/week)1.6--2.2 g30--40 Hz15--60 s × Pos. exercise, 60 s till 5 min rest between exercisesSidealternating sinusoidal vibrationBeck et al. \[[@CR35]\]32 weeks/(2/week)2 mm12.5 Hz2 sets × 3 min, 60 s rest between setCalder et al. \[[@CR39]\]6 weeks2 mm20 Hz4 sets × 75 s, 90 s rest between setCorrie et al. \[[@CR65]\]12 weeks/(3/week)2.9 mm30 Hz3 to 6 sets × 20 to 60 s, 60 s rest between setFurness and Maschette \[[@CR40]\]6 weeks0.05 mm15--25 Hz5 sets × 60 s, 60 s rest between setFurness et al. \[[@CR41]\]6 weeks/(3/week)1 mm15--25 Hz5 sets × 60 s, 60 s rest between setsIwamoto et al. \[[@CR43]\]18 weeks/(2/week)NA20 Hz4 min, NA restKlarner et al. \[[@CR40]\]48 weeks/(3/week)3--7 mm12,5 Hz7 sets × 90 s, 40 s rest between setOchi et al. \[[@CR67]\]12 weeks/(3/week)12 mm2,5 Hz180 s, no restRaimundo et al. \[[@CR50]\]32 weeks/(3/week)6 mm20--30 Hz3 sets × 60 s, 60 s rest between setRees et al. \[[@CR51]\]8 weeks/(3/week)5--8 mm26 Hz6 sets × 45 up to 60 s, 5 × 45 up to 80 s rest between setRees et al. \[[@CR52]\]8 weeks/(3/week)5--8 mm26 Hz6 sets × 45--80 s, 45--80 s rest between setRusso et al. \[[@CR55]\]24 weeks/(2/week)NA12--28 Hz3 sets × 60--120 s, 60 s rest between setSievänen et al. \[[@CR61]\]10 week/(2/week)2--8 mm12 and 18 Hz1--5 sets × 60--120 s, 60 s rest between setStolzenberg et al. \[[@CR56]\]36 weeks/(2/week)NA22--26 Hz60--90 s, rest (NA)von Stengel et al. \[[@CR59]\]74 weeks/(2weeks)1.7--2 mm25--35 Hz6 sets × 60 s, 60 s rest between setZhang et al. \[[@CR60]\]8 weeks/(3--5/week)1--3 mm25--35 Hz4--5 sets × 60 s, 60 s rest between setStochastic resonance vibrationKessler et al. \[[@CR23]\]4 weeks/(3/week)--3--6 Hz (Noise 4)5 sets × 60 s, 60 s rest between setRogan et al. \[[@CR54]\]4 weeks/(3/week)--5 Hz (Noise 4)5 sets × 60 s, 60 s rest between setRogan et al. \[[@CR20]\]Immediately (acute effects)6 Hz (Noise 4)5 sets × 60 s, 60 s rest between set*Abbreviation*: *mo* month, *wk* week, *s* seconds, *Hz* hertz, *NA* not available

Study methodological quality {#Sec12}
----------------------------

All studies included in Fig. [2](#Fig2){ref-type="fig"} were at risk of bias according to the "Cochrane Collaboration's tool for assessing risk of bias". Most studies lacked allocation concealment, blinding, and presented incomplete data.Fig. 2Risk of bias

Meta-analysis {#Sec13}
-------------

For the meta-analysis 37 studies were included and data were available for IMVC, DS, power, RFD or FS outcome measurements. The effect sizes for these outcomes are summarized in Figs. [3](#Fig3){ref-type="fig"}, [4](#Fig4){ref-type="fig"}, [5](#Fig5){ref-type="fig"}, [6](#Fig6){ref-type="fig"}, [7](#Fig7){ref-type="fig"}, [8](#Fig8){ref-type="fig"}, [9](#Fig9){ref-type="fig"}, [10](#Fig10){ref-type="fig"}, [11](#Fig11){ref-type="fig"}, [12](#Fig12){ref-type="fig"} and [13](#Fig13){ref-type="fig"}.Fig. 3Comparison of WBV versus control group (i.e. no exercise), outcome: maximal voluntary isometric contraction. *SMD* standardized mean difference, *SD* standard deviation, *95 % CI* confidence interval, *I* ^*2*^ statistic for heterogeneity, *WBV* whole-body vibrationFig. 4Comparison of WBV versus exercise group (i.e. no exercise), outcome: maximal voluntary isometric contraction. *SMD* standardized mean difference, *SD* standard deviation, *95 % CI* confidence interval, *I* ^*2*^ statistic for heterogeneity, *WBV* whole-body vibrationFig. 5Comparison of WBV versus control group (i.e. no exercise) outcome: dynamic strength. *SMD* standardized mean difference, *SD* standard deviation, *95 % CI* confidence interval, *I* ^*2*^ statistic for heterogeneity, *WBV* whole-body vibrationFig. 6Comparison of WBV versus exercise group; outcome: dynamic strength. *SMD* standardized mean difference, *SD* standard deviation, *95 % CI* confidence interval, *I* ^*2*^ statistic for heterogeneity, *WBV* whole-body vibrationFig. 7Comparison of WBV versus control group (i.e. no exercise) outcome: power. *SMD* standardized mean difference, *SD* standard deviation, *95 % CI* confidence interval, *I* ^*2*^: statistic for heterogeneity, *WBV* whole-body vibrationFig. 8Comparison of WBV versus exercise group; outcome: power. *SMD* standardized mean difference, *SD* standard deviation, *95 % CI* confidence interval, *I* ^*2*^ statistic for heterogeneity, *WBV* whole-body vibrationFig. 9Comparison of WBV versus control group (i.e. no exercise), outcome: rate of force development. *SMD* standardized mean difference, *SD* standard deviation, *95 % CI* confidence interval, *I* ^*2*^ statistic for heterogeneity, *WBV* whole-body vibrationFig. 10Comparison of WBV versus exercise group, outcome: rate of force development. *SMD* standardized mean difference, *SD* standard deviation, *95 % CI* confidence interval, *I* ^*2*^ statistic for heterogeneity, *WBV* whole-body vibrationFig. 11Comparison of WBV versus control group (i.e. no exercise), outcome: functional strength. *SMD* standardized mean difference, *SD* standard deviation, *95 % CI* confidence interval, *I* ^*2*^ statistic for heterogeneity, *WBV* whole-body vibrationFig. 12Comparison of WBV versus exercise group, outcome: functional strength. *SMD* standardized mean difference, *SD* standard deviation, *95 % CI* confidence interval, *I* ^*2*^ statistic for heterogeneity, *WBV* whole-body vibrationFig. 13Funnel plot over all analysis

### Isometric maximal voluntary contraction: WBV vs. non-exercise control group {#Sec14}

Thirteen studies \[[@CR20], [@CR23], [@CR36]--[@CR38], [@CR45], [@CR46], [@CR48], [@CR53], [@CR57]--[@CR59], [@CR67]\], including 1468 participants, reported data contributing to the comparison WBV vs. non-exercise control group, one study had two WBV-arms (vertical and side-alternating) and one control arm \[[@CR46]\] (the number of participants in the control groups was cut in half to obtain correct numbers for the pooled analysis). The pooled overall SMD was 0.44 (95 % CI 0.30 to 0.58) in favor of WBV with low heterogeneity, I^2^ 25.9 % (*p* = 0.176).

### Go-Go {#Sec15}

The subgroup analysis for SV-WBV-Go-Go showed a SMD of 0.48 (95 % CI 0.33 to 0.63) with a low heterogeneity (I^2^ 10.8 % (*p* = 0.346)); and for SS-WBV-Go-Go a SMD of 0.69 (95 % CI 0.32 to 1.06) with a low heterogeneity, I^2^ 9.8 % (*p* = 0.292).

### Slow-Go {#Sec16}

The subgroup analysis for SV-WBV-Slow-Go revealed a SMD of 0.14 (95 % CI −0.13 to 0.41) with a low heterogeneity, I^2^ 5.6 % (*p* = 0.303).

### No-Go {#Sec17}

The subgroup analysis for SR-WBV-No-Go showed a SMD of 0.27 (95 % CI −0.34 to 0.88) in favour of SR-WBV with no heterogeneity, I^2^ 0.0 % (*p* = 0.995) (Fig. [3](#Fig3){ref-type="fig"}).

### Isometric maximal voluntary contraction: WBV vs. exercise group {#Sec18}

For the comparison WBV versus conventional exercise eight studies \[[@CR37], [@CR38], [@CR45], [@CR53], [@CR58]--[@CR60], [@CR68]\] contributed 460 participants. The pooled overall SMD was 0.01 (95 % CI −0.21 to 0.22) with a low heterogeneity, I^2^ = 21.9 % (*p* = 0.255).

### Go-Go {#Sec19}

The subgroup analysis for SV-WBV-Go-Go showed a SMD of −0.16 (95 % CI −0.38 to 0.06) with a low heterogeneity, I^2^ 0.0 % (*p* = 0.966); SS-WBV-Go-Go showed an SMD of 0.24 (95 % CI −0.17 to 0.65) in favour of SS-WBV.

### Slow-Go {#Sec20}

The subgroup analysis for SS-WBV-Slow-Go showed a SMD of −0.04 (95 % CI −0.92 to 0.84) in favour of conventional exercise.

### No-Go {#Sec21}

The subgroup analysis for SS-WBV-No-Go showed a SMD of 0.77 (95 % CI 0.10 to 1.44) in favour of SS-WBV.

### Dynamic strength: WBV vs. non-exercise control {#Sec22}

Comparing dynamic strength in WBV versus non-exercise controls, six studies \[[@CR45], [@CR49], [@CR51], [@CR53], [@CR57], [@CR58]\] contributed with a total of 312 participants. The pooled overall SMD was 0.34 (95 % CI 0.06 to 0.61), which was statistically significant in favour of the WBV group, with low heterogeneity (I^2^ 26.7 %, *p* = 0.234).

### Go-Go {#Sec23}

The subgroup analysis for SV-WBV-Go-Go showed a SMD of 0.47 (95 % CI 0.06 to 0.88) in favour of SV-WBV with a low heterogeneity, I^2^ 38.6 %, *p* = 0.180. The subgroup analysis for SS-WBV-Go-Go showed a SMD of 0.38 (95 % CI −0.34 to 1.11) in favour of SS-WBV.

### Slow-Go {#Sec24}

The subgroup analysis for SV-WBV-Slow-Go showed a SMD of 0.09 (95 % CI −0.28 to 0.46).

### Dynamic strength: WBV vs. conventional exercise {#Sec25}

For the comparison WBV versus conventional exercise seven studies \[[@CR45], [@CR50]--[@CR52], [@CR58], [@CR59], [@CR53]\] contributed with a total of 245 participants. The pooled overall SMD was 0.08 (95 % CI −0.34 to 0.17), statistically non-significant, thus, not in favour of a particular group, with no heterogeneity (I^2^ 0.0 %, *p* = 0.539).

### Go-Go {#Sec26}

The subgroup analysis for SV-WBV-Go-Go showed a SMD of −0.25 (95 % CI −0.59 to 0.08) in favour of exercise, with no heterogeneity, I^2^ 0.0 % (*p* = 0.639). The subgroup analysis for SS-WBV-Go-Go showed a SMD of 0.16 (95 % CI −0.27 to 0.60) statistically not significant in favour of SS-WBV with no heterogeneity, I^2^ 0.0 % (*p* = 0.415).

### Slow-Go {#Sec27}

The subgroup analysis for SV-WBV-Slow-Go showed a SMD of 0.08 (95 % CI −0.77 to 0.94).

### Power: WBV vs. non-exercise control {#Sec28}

For the outcome power and the comparison WBV versus non-exercise control five studies \[[@CR48], [@CR49], [@CR55], [@CR56], [@CR66]\] contributed with a total of 186 participants. The control group of the Corrie et al. \[[@CR65]\] study contributed to two subgroup analyses, therefore, we cut the number of participants in the control group in half to avoid incorrect standard errors.

### Go-Go {#Sec29}

The pooled overall SMD was 0.22 (95 % CI −0.19 to 0.64), statistically non-significant in favour of the WBV group, with a moderate heterogeneity (I^2^ 44.7 %, *p* = 0.107).

The subgroup analysis for SV-WBV-Go-Go showed a SMD of −0.45 (95 % CI −1.14 to 0.25), with low heterogeneity, I^2^ 17.3 % (*p* = 0.271). SS-WBV-Go-Go showed a SMD of 0.50 (95 % CI 0.07 to 0.92) statistically significant in favour of SS-WBV with no heterogeneity, I^2^ 0.0 % (*p* = 0.405).

### Slow-Go {#Sec30}

The subgroup analysis for SV-WBV-Slow-Go showed a SMD of 0.73 (95 % CI −0.09 to 1.55). SS-WBV-Slow-Go showed a SMD of 0.31 (95 % CI −0.49 to 1.12) statistically not significant in favour of SS-WBV.

### Power: WBV vs. conventional exercise {#Sec31}

Three studies \[[@CR34], [@CR50], [@CR52]\] with 76 participants contributed to the comparison SS-WBV versus conventional exercise. The SMD was 0.39 (95 % CI −0.11 to 0.90), statistically not significant in favour of the WBV group.

### Go-Go {#Sec32}

The subgroup analysis for SS-WBV-Go-Go showed a SMD of 0.63 (95 % CI 0.08 to 1.17), statistically significant in favour of SS-WBV with no heterogeneity, I^2^ 0.0 % (*p* = 0.879).

### Slow-Go {#Sec33}

The subgroup analysis for SV-WBV-Slow-Go showed a SMD of −0.17 (95 % CI −1.03 to 0.69), statistically not significant in favour of conventional exercise.

### Rate of force development: WBV vs. non-exercise control {#Sec34}

For the outcome rate of force development and the comparison WBV versus non-exercise control eight studies \[[@CR34], [@CR37], [@CR45], [@CR46], [@CR55], [@CR56], [@CR66], [@CR53]\] contributed with a total of 500 participants. The control groups of two studies \[[@CR46], [@CR66]\] contributed to two subgroup analyses, therefore, we divided the number of participants in the control groups in half. The pooled overall SMD was 0.33 (95 % CI 0.14 to 0.52), statistically significant in favour of the WBV group with low heterogeneity (I^2^ 6.1 %, *p* = 0.385).

### Go-Go {#Sec35}

The subgroup analysis for SV-WBV-Go-Go showed a SMD of 0.39 (95 % CI 0.08 to 0.71) in favour of conventional exercise with no heterogeneity, I^2^ 0.0 % (*p* = 0.455). SS-WBV-Go-Go showed a SMD of 0.40 (95 % CI 0.16 to 0.64) and statistically significant in favour of SS-WBV with no heterogeneity, I^2^ 0.0 % (*p* = 0.516).

### Slow-Go {#Sec36}

The subgroup analysis for SV-WBV-Slow-Go showed a SMD of −0.45 (95 % CI −1.25 to 0.36). The subgroup analysis for SS-WBV-Slow-Go showed a SMD of 0.00 (95 % CI −0.80 to 0.80).

### Rate of force development: WBV vs. conventional exercise {#Sec37}

For the comparison WBV versus conventional exercise six studies \[[@CR34], [@CR37], [@CR45], [@CR50], [@CR59], [@CR53]\] contributed with a total of 285 participants. The pooled overall SMD was 0.13 (95 % CI −0.11 to 0.36), statistically non-significant in favour of the WBV group, with no heterogeneity (I^2^ 0.0 %, *p* = 0.452).

### Go-Go {#Sec38}

The subgroup analysis for SV-WBV-Go-Go showed a SMD of −0.06 (95 % CI −0.39 to 0.26) in favour of exercise, with no heterogeneity, I^2^ 0.0 % (*p* = 0.805). SS-WBV-Go-Go showed a SMD of 0.40 (95 % CI 0.04 to 0.76), statistically significant in favour of SS-WBV with no heterogeneity, I^2^ 0.0 % (*p* = 0.405).

### Slow-Go {#Sec39}

The subgroup analysis for SV-WBV-Slow-Go showed a SMD of −0.10 (95 % CI −0.95 to 0.76).

### Functional strength: WBV vs. non-exercise control {#Sec40}

For the outcome functional strength and the comparison WBV versus non-exercise control 17 studies \[[@CR20], [@CR23], [@CR35], [@CR37], [@CR39]--[@CR43], [@CR45], [@CR49], [@CR51], [@CR54]--[@CR56], [@CR59], [@CR64], [@CR53]\] contributed with a total of 565 participants (one study has SS-WBV and SV-WBV versus control, therefore we cut the number of participants of the control group in half) \[[@CR35]\]. The pooled overall SMD was 0.40 (95 % CI 0.20 to 0.60), statistically non-significant in favour of the WBV group with low heterogeneity (I^2^ 24.6 %, *p* = 0.159).

### Go-Go {#Sec41}

The subgroup analysis for SV-WBV-Go-Go showed an SMD of 0.25 (95 % CI −0.189 to 0.67), statistically non-significant in favour of exercise with no heterogeneity, I^2^ 0.0 % (*p* = 0.893).SS-WBV-Go-Go showed a SMD of 0.42 (95 % CI 0.13 to 0.71) statistically significant in favour of SS-WBV with low heterogeneity, I^2^ 27.5 % (*p* = 0.209).

### Slow-Go {#Sec42}

The subgroup analysis for SV-WBV-Slow-Go showed an SMD of −0.33 (95 % CI −1.26 to 1.91) with high heterogeneity, I^2^ 87.3 % (*p* = 0.005). The subgroup analysis for SS-WBV-Slow-Go showed a SMD of 0.41 (95 % CI −0.40 to 1.21), statistically non-significant in favour of SS-WBV with moderate heterogeneity, I^2^ 58.4 % (*p* = 0.121).

### No-Go {#Sec43}

The subgroup analysis for SS-WBV-No-Go showed a SMD of 0.24 (95 % CI −0.85 to 1.34). The subgroup analysis for SR-WBV-Slow-Go showed a SMD of 0.97 (95 % CI −0.07 to 2.00). The subgroup analysis for SR-WBV-No-Go showed a SMD of 0.50 (95 % CI −0.32 to 1.33), statistically non-significant in favour of SR-WBV, with a moderate heterogeneity, I^2^ 42.5 % (*p* = 0.187).

### Functional strength: WBV vs. conventional exercise {#Sec44}

For the comparison WBV versus conventional exercise five studies \[[@CR47], [@CR50], [@CR51], [@CR60], [@CR64]\] contributed with a total of 306 participants. The pooled overall SMD was −0.20 (95 % CI −0.67 to 0.27), statistically non-significant in favour of the conventional exercise group with substantial heterogeneity (I^2^ 70.0 %, *p* = 0.010).

### Go-Go {#Sec45}

The subgroup analysis for SV-WBV-Go-Go showed a SMD of −0.52 (95 % CI −1.06 to 0.02), statistically non-significant in favour of conventional exercise. The subgroup analysis for SS-WBV-Go-Go showed a SMD of −0.50 (95 % CI −2.01 to 1.02) with high heterogeneity, I^2^ 86.3 % (*p* = 0.007).

### Slow-Go {#Sec46}

The subgroup analysis for SV-WBV-Slow-Go showed a SMD of −0.07 (95 % CI −0.38 to 0.24).

### No-Go {#Sec47}

The subgroup analysis for SS-WBV-No-Go showed a SMD of 0.44 (95 % CI −0.21 to 1.09), statistically non-significant in favour of SS-WBV.

Over all comparisons, only the comparisons of WBV versus non-exercise control for the outcomes isometric strength had a significant Egger's test (*p* = 0.002) for small study bias. Funnel plots for individual comparison are not shown. Figure [13](#Fig13){ref-type="fig"} shows a panel of the funnel plots for all comparisons.

The effect sizes in the studies with participants in the No-Go group (SMD of 0.47, 95 % CI 0.16 to 0.78, I^2^ 0.00 %, *p* \<0.792) were higher compared to the Go-Go (SMD 0.26, 95 % CI 0.15 to 0.63, I^2^ 48.9 %, *p* \<0.001) and the Slow-Go groups (SMD of 0.14, 95 % CI −0.04 to 0.33, I^2^ 26.6 %, *p* = 0.121) (see Table [3](#Tab3){ref-type="table"} and Additional files [2](#MOESM2){ref-type="media"}, [3](#MOESM3){ref-type="media"} and [4](#MOESM4){ref-type="media"}).Table 3Overview of WBV utilization on physical performance statusGo-GoSlow-GoNo-GoVS-WBVVS-WBV1Amaral et al. \[[@CR78]\] (SA) FS1Alvarez et al. \[[@CR62]\] FS2Beck et al. \[[@CR35]\] FS2Bautmans \[[@CR34]\] DS, Power, RFD3Boegarts et al. \[[@CR37]\] IMVC, RFD3Boegarts et al. \[[@CR36]\] IMVC4Boegarts et al. \[[@CR38]\] IMVC4Corrie et al. \[[@CR6]\] Power, FS, RFD5Gomez-Cabello et al. \[[@CR42]\] FS5Sitja-Rabert et al. \[[@CR68]\] FS6Kemmler et al. \[[@CR44]\] IMVC, Power,6Verscheuern et al. \[[@CR57]\] IMVC, DS7RFD8Kennis et al. \[[@CR45]\] IMVC, DS, RFD9Klarner et al. \[[@CR46]\] IMVC, RFD10Lachane \[[@CR47]\] FS11Leung et al. \[[@CR66]\] IMVC12Machado et al. \[[@CR48]\] MVC, Power13Mikhael et al. \[[@CR49]\] DS, Power, FS14Roelants et al. \[[@CR53]\] IMVC, DS, RFD15Verscheuren et al. \[[@CR58]\] IMVC, DSSS-WBVSS-WBVSS-WBV1Beck et al. \[[@CR35]\] FS1Calder et al. \[[@CR39]\] FS1Sievänen et al. \[[@CR61]\] FS2Furness and Maschette \[[@CR40]\] FS2Corrie et al. \[[@CR65]\] Power, RFD, FS2Zhang et al. \[[@CR60]\] IMVC, FS3Furness et al. \[[@CR41]\] FS3Ochi et al. \[[@CR67]\] IMVC4Iwamoto et al. \[[@CR43]\] FS5Klarner et al. \[[@CR46]\] IMVC, RFD6Raimundo et al. \[[@CR50]\] DS, Power, RFD; FS7Rees et al. \[[@CR51]\] DS, FS8Rees et al. \[[@CR52]\] DS, Power9Russo et al. \[[@CR55]\] DS, RFD10Stolzenberg et al. \[[@CR56]\] Power, RFD, FS11von Stengel et al. \[[@CR59]\] IMVC, RFDSR-WBVSR-WBV11Rogan et al. \[[@CR54]\] FS1Kessler et al. \[[@CR23]\] IMVC, RFD, FS22Rogan et al. \[[@CR20]\] IMVC, IRFD, FSSMD 0.26 (95 % CI 0.15 to 0.63)SMD of 0.14 (95 % CI −0.04 to 0.33)SMD of 0.47 (95 % CI 0.16 to 0.78)I^2^ 48.9 %, *p* \<0.001I^2^ 26.6 %, *p* = 0.121I^2^ 0.00 %, *p* \<0.792*Abbreviation: VS-WBV* vertical sinusoidal whole-body vibration, *SS-WBV* side-alternating whole-body vibration; *SR-WBV* stochastic resonance whole-body vibration, *IMVC* isometric maximal voluntary contraction, *DS* dynamic maximal strength, *RFD* rate of force development, *IRFD* isometric rate of force development, *FS* functional strength, SMD, *I* ^*2*^ I^2^ --statistic for heterogeneity

Discussion {#Sec48}
==========

We hypothesized that WBV differently effects on measures of strength and power in Go-Go, Slow-Go and No-Go. This systematic review on muscle-strength-related outcomes of WBV in healthy elderly participants included 37 studies in a final analysis, most of which were studies with small sample sizes. The main findings were that WBV showed low to moderate effects in Go-Go, Slow-Go and No-Go when compared to non-exercising control groups on proxies of muscle strength in older adults. Furthermore, compared to groups performing more conventional types of exercise, WBV had only small and mostly non-significant advantages. Although only a few studies evaluated the effects of WBV in samples of elderly participants in need of care (classified as No-Go \[[@CR10]\] in this review), the highest effect sizes favouring WBV were found in these studies. The few studies that evaluated SR-WBV also resulted in high effect sizes in favour of this type of WBV in No-Go. These findings seem to confirm our hypothesis. However, when we summarized the effect sizes of the meta-analysis and intended to perform statistical analysis on these data that would either refute or confirm our hypothesis, the amount of data was not big enough and the groups too unbalanced in size to allow a credible analysis to be performed. Further studies in No-Go are, therefore, warranted and needed with the various types of WBV. This means regarding our aim to give recommendations on available evidence for practical use the inference must be that at present no recommendations can be given for the most effective vibration mode in elderly persons.

Our review classified the physical capacities of the included participants (i.e. in "Go-Go", "Slow-Go", and "No-Go" \[[@CR10]\]) and analysed studies with WBV versus non-exercising control separately from studies comparing WBV versus other types of conventional strength training exercise, as recommended by Orr \[[@CR68]\]. Furthermore, we separately analyzed studies using vertical, side-alternating and stochastic resonance WBV. The reason for these distinctions relate to the assumption that initial fitness when entering a training program together with the training content may differently effect on training outcomes. Physical fitness includes health-related (cardiorespiratory endurance, muscular endurance, muscular strength, flexibility and body composition) and skill-related components (agility, coordination, balance, speed, reaction time and power) \[[@CR69]\]. Although exercise recommendations have been published for older adults; e.g. the American College of Sports Medicine (ACSM) \[[@CR70]\] guidelines recommend that older adults should undertake 30 min of moderate intensity, aerobic exercise or activity, five times per week to incur any health benefits, the complex interactions present in various sub-populations of older adults preclude the definition of specific, detailed exercise prescriptions. Furthermore, the number of older people fulfilling the ACSM requirement is rather small and most likely even lower amongst those with low levels of functioning \[[@CR71]\]. It seems fair to assume that when principles of exercise training are applied to the development of exercise protocols, clinicians in practical settings can have greater confidence that non-significant research findings reflect deficiencies in exercise efficacy rather than deficiencies in exercise prescription \[[@CR72]\]. It is thereby important, however, to consider low baseline fitness and mobility levels in pre-frail or frail or rather untrained elderly when starting an exercise program. Based on the findings of this systematic review it seems that the use of (SR)-WBV is valuable for untrained or frail elderly where the neuromuscular systems might not be able withstanding higher loading and long training sessions, however, with increasing levels of functioning there is a diminishing effect of the WBV interventions. Considering this it becomes clear that this systematic review only reveals first estimates for the possible effect of WBV in (pre-)frail elderly. An important next step would be the design and implementation of a sufficiently powered WBV exercise study specifically targeting (pre-)frail institutionalised elderly with a training duration of at least 2 months since this is the duration where effects of WBV training in the elderly may be expected \[[@CR73]\].

Role of physical capacity level {#Sec49}
-------------------------------

Altough we did not find a systematic review on WBV that used a classification of participants in different subgroups of functioning, our conclusion is in line with similar previously expressed conclusions. Lau et al. \[[@CR24]\] mainly focussed on bone mineral density but also included strength measures. They concluded, that WBV is beneficial in elderly persons to increase muscle strength. However, because they did not use a separate analysis for different groups with different levels of physical capacities it is difficult to determine whether the effects observed are dependent on the baseline fitness of the study participants. Sitja-Rabert et al. \[[@CR25]\] concluded that WBV was beneficial in elderly participants to improve strength. Osawa et al. \[[@CR74]\] included both young and elderly participants and concluded that WBV in addition to exercises or to a normal lifestyle improved knee extensor strength and countermovement jump performance when compared to identical training conditions without WBV.

WBV as skilling-up exercise {#Sec50}
---------------------------

Our findings seem to justify the assumption, that WBV might be applicable as a "skilling-up" exercise for elderly with low physical capacity (i.e. the No-Go group), who are considering to begin with an exercise program, but who are not yet able to perform traditional strength exercises. A short bout of vibration would produce sufficient stimuli to effect on muscle strength, power and functional tasks. There are some theoretical explanations that WBV might improve the neuromuscular drive, which improves muscular function \[[@CR18], [@CR75]\]. In contrary to the No-Go group, elderly persons in the Go-Go and the Slow-Go group can perform standard exercises and WBV might be an additional option among all exercise modalities. The measured effects sizes for the Go-Go and Slow-Go groups were not very high and not all outcomes showed significant differences in the included studies. For this reason, WBV should be rather used for "skilling-up" in pre-frail or frail elderly individuals.

Limitations of this study {#Sec51}
-------------------------

There are some limitations of this review. The included studies presented moderate to high risk of bias, allocation concealment was not described in most studies, groups were often not similar at baseline (which is often the case in small studies), participants were blinded in only seven studies and outcome assessors were blinded in only 11 studies. With the exception of Leung et al. \[[@CR66]\], Boegarts et al. \[[@CR38]\], Kemmler et al. \[[@CR44]\], von Stengel \[[@CR59]\] (*n* = 151) and Sitjà-Rabert et al. \[[@CR64]\], the remaining studies were small. This further increases the risk of bias. Therefore, the quality of the included studies overall was rather low.

The ability to replicate or reproduce experimental results, or reproducibility, is one of the major tenets of the scientific method. SR-WBV results considered in this review come from one research group only. It is, therefore, necessary that the published findings of this group are validated through replication by others. Until replication is done the results for SR-WBV should be interpreted with caution and, hence, this is a limitation of this review. Another limitation of our approach is the possible language bias, we only included studies in English or German and it cannot be excluded that relevant research in different languages exists.

This review included mainly studies with "Go-Go" and "Slow-Go" participants and only few studies with participants from the "No-Go" group. As the effect might be largest in this No-Go group with SMD of 0.47 (95 % CI 0.16 to 0.78), further studies should evaluate WBV in this group of elderly. Only a few studies have evaluated SR-WBV and no study has compared SR-WBV to other vibration modalities in elderly participants.

Conclusions {#Sec52}
===========

WBV shows beneficial effects on proxies of muscle strength in older adults, mainly in elderly with lower initial levels of functioning, suggesting that WBV can be used as a skilling-up exercise in participants. However, the review suggests that WBV has no overall treatment effect on muscle strength properties in older women and men across the whole spectrum of physical functioning. Only few studies evaluated WBV in (pre-)frail elderly. No randomized trial has examined the effects of WBV on muscle in older (pre-)frail elderly. Based on this review no recommendations can be given for the most effective vibration mode. Further studies with the various types of WBV in various sub-populations of elderly persons are warranted and needed to determine the most effective vibration modes.
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CENTRAL

:   Cochrane Central Register of Controlled Trials

DS

:   dynamic strength

FS

:   functional strength

Go-Go

:   independent person

IMVC

:   isometric maximum voluntary contraction

No-Go

:   person depending permanently on assistance with severe functional limitation

PEDro

:   Physiotherapy Evidence Database

RFD

:   rate of force development

Slow-Go

:   depending on support in everyday activities such as dressing, body care, eating, using the toilet, mobility, and planning the day

SMD

:   standardised mean differences

SR-WBV

:   stochastic resonance whole-body vibration

SS-WBV

:   side-alternating sinusoidal whole-body vibration

SV-WBV

:   sinusoidal vertical whole-body vibration

WBV

:   whole-body vibration

WHO

:   World Health Organization
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